Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-09 · 1879 (5) · 189176
DOI: 10.1016/j.bbcan.2024.189176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-09. Verfasst von Wentao Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China; Oncology Department of Traditional…. Hauptthemen laut MEDLINE: Neoplasms, Sphingolipids, Signal Transduction, Extracellular Vesicles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 617 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sphingolipids, crucial components of cellular membranes, play a vital role in maintaining cellular structure and signaling integrity. Disruptions in sphingolipid metabolism are increasingly implicated in cancer development. Key bioactive sphingolipids, such as ceramides, sphingosine-1-phosphate (S1P), ceramide-1-phosphate (C1P), and glycosphingolipids, profoundly impact tumor biology. They influence the behavior of tumor cells, stromal cells, and immune cells, affecting tumor aggressiveness, angiogenesis, immune modulation, and extracellular matrix remodeling. Furthermore, abnormal expression of sphingolipids and their metabolizing enzymes modulates the secretion of tumor-derived extracellular vesicles (TDEs), which are key players in creating an immunosuppressive tumor microenvironment, remodeling the extracellular matrix, and facilitating oncogenic signaling within in situ tumors and distant pre-metastatic niches (PMNs). Understanding the role of sphingolipids in the biogenesis of tumor-derived extracellular vesicles (TDEs) and their bioactive contents can pave the way for new biomarkers in cancer diagnosis and prognosis, ultimately enhancing comprehensive tumor treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Practice, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China; Oncology Department of Traditional Chinese Medicine, The First Affiliated Hospital of Naval Medical Univ…
- Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
- Department of Pharmacy, Tianjin Rehabilitation and Recuperation Center, Joint Logistics Support Force, Tianjin 300000, China.
- Department of Gastroenterology, Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201900, China.
- Oncology Department of Traditional Chinese Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai 200043,…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jia, W., Yuan, J., Zhang, J., Li, S., Lin, W., & Cheng, B. (2024). Bioactive sphingolipids as emerging targets for signal transduction in cancer development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(5), 189176. https://doi.org/10.1016/j.bbcan.2024.189176
Vancouver
Jia W, Yuan J, Zhang J, Li S, Lin W, Cheng B. Bioactive sphingolipids as emerging targets for signal transduction in cancer development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(5):189176. doi:10.1016/j.bbcan.2024.189176
BibTeX
@article{Jia2024,
author = {Jia, Wentao and Yuan, Jiaying and Zhang, Jinbo and Li, Shu and Lin, Wanfu and Cheng, Binbin},
title = {Bioactive sphingolipids as emerging targets for signal transduction in cancer development},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
volume = {1879},
number = {5},
pages = {189176},
doi = {10.1016/j.bbcan.2024.189176}
}
EUVIMED